Elisabet Salsench
Biographic Data
| ID | 7761966 |
|---|---|
| NAME | Elisabet Salsench |
| GIVEN NAMES | Elisabet |
| FAMILY NAME | Salsench |
| SIGNATURE | SALSENCH E |
| AFFILIATIONS | Institut Català de la Salut |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2010 |
| LATEST PUBLICATION YEAR | 2012 |
| H-INDEX | 0 |
Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years
Our data supports a benefit of PPV23 against ischaemic stroke among the general population over 60 years, suggesting a possible protective role of pneumococcal vaccination against some acute thrombotic events
Rationale and design of the Capamis study
The results of the study will contribute to clarify the controversial effect of the PPV-23 in preventing community-acquired pneumonia and they will be critical in determining the possible role of pneumococcal vaccination in cardiovascular prevention
No prominent works on this page.
Rationale and design of the Capamis study
The results of the study will contribute to clarify the controversial effect of the PPV-23 in preventing community-acquired pneumonia and they will be critical in determining the possible role of pneumococcal vaccination in cardiovascular prevention
Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years
Our data supports a benefit of PPV23 against ischaemic stroke among the general population over 60 years, suggesting a possible protective role of pneumococcal vaccination against some acute thrombotic events
Cohort study (2 works) · Environmental health (2 works) · Hazard ratio (2 works) · Immunology (2 works) · Influenza Virus Research Studies (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Myocardial infarction (2 works) · Population (2 works) · Stroke (engine (2 works)